Curaleaf (OTCMKTS:CURLF) Posts Earnings Results, Beats Expectations By $0.02 EPS

Curaleaf (OTCMKTS:CURLF) announced its quarterly earnings data on Tuesday. The company reported ($0.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.02, Zacks reports. Curaleaf had a positive return on equity of 0.43% and a negative net margin of 0.76%. The business had revenue of $352.65 million for the quarter, compared to analyst estimates of $346.46 million.

Curaleaf Trading Down 2.1%

OTCMKTS CURLF traded down $0.20 during trading hours on Thursday, reaching $9.38. The company had a trading volume of 25,429 shares, compared to its average volume of 281,538. The stock has a 50-day moving average of $9.56 and a 200 day moving average of $8.32. The company has a current ratio of 1.52, a quick ratio of 0.73 and a debt-to-equity ratio of 1.06. Curaleaf has a 1-year low of $5.40 and a 1-year high of $15.15. The stock has a market capitalization of $2.19 billion, a P/E ratio of -234.62 and a beta of 1.62.

Analysts Set New Price Targets

CURLF has been the topic of a number of research reports. Citigroup reiterated a “buy” rating on shares of Curaleaf in a research note on Thursday, August 6th. Zacks Research lowered shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 13th. Finally, UBS Group set a $6.00 target price on shares of Curaleaf in a research note on Monday, October 5th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $6.00.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, distributes and sells cannabis products for medical and adult-use markets. Its portfolio includes cannabis flower, pre-rolls, vaporizers, concentrates, edibles, tinctures, capsules, topicals and other wellness products, offered under brands such as Curaleaf, Select and Grassroots.

The company serves customers through a network of retail dispensaries and wholesale channels in regulated U.S. cannabis markets. Its operations include cultivation and manufacturing facilities as well as dispensaries, with products distributed in multiple states where medical or adult-use cannabis is permitted.